Fidelity Investments’s Array Biopharma Inc ARRY Stock Holding History

Fidelity Investments’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-19,206,726	Closed	-$890M	–	4453
2019 Q2	$890M	Sell	19,206,726 -13,100,628	-41%	-$607M	0.1%	191
2019 Q1	$788M	Buy	32,307,354 +613,852	+2%	+$15M	0.09%	204
2018 Q4	$452M	Buy	31,693,502 +4,591,866	+17%	+$65.4M	0.06%	308
2018 Q3	$412M	Buy	27,101,636 +2,711,240	+11%	+$41.2M	0.05%	393
2018 Q2	$409M	Buy	24,390,396 +787,460	+3%	+$13.2M	0.05%	381
2018 Q1	$385M	Buy	23,602,936 +1,421,000	+6%	+$23.2M	0.05%	415
2017 Q4	$284M	Sell	22,181,936 -55,600	-0.3%	-$712K	0.03%	553
2017 Q3	$274M	Buy	22,237,536 +3,705,200	+20%	+$45.6M	0.03%	560
2017 Q2	$155M	Sell	18,532,336 -4,743,500	-20%	-$39.7M	0.02%	779
2017 Q1	$208M	Sell	23,275,836 -1,524,300	-6%	-$13.6M	0.03%	677
2016 Q4	$218M	Buy	24,800,136 +286,752	+1%	+$2.52M	0.03%	630
2016 Q3	$165M	Buy	24,513,384 +11,350,193	+86%	+$76.6M	0.02%	762
2016 Q2	$46.9M	Sell	13,163,191 -248,500	-2%	-$885K	0.01%	1302
2016 Q1	$39.6M	Sell	13,411,691 -5,268,406	-28%	-$15.5M	0.01%	1347
2015 Q4	$78.8M	Buy	18,680,097 +16,706	+0.1%	+$70.5K	0.01%	1063
2015 Q3	$85.1M	Buy	18,663,391 +167,000	+0.9%	+$762K	0.01%	1028
2015 Q2	$133M	Sell	18,496,391 -45,100	-0.2%	-$325K	0.02%	895
2015 Q1	$137M	Buy	18,541,491 +7,315,521	+65%	+$53.9M	0.02%	889
2014 Q4	$53.1M	Sell	11,225,970 -226,500	-2%	-$1.07M	0.01%	1302
2014 Q3	$40.9M	Buy	11,452,470 +3,400	+0%	+$12.1K	0.01%	1383
2014 Q2	$52.2M	Sell	11,449,070 -1,019,400	-8%	-$4.65M	0.01%	1324
2014 Q1	$58.6M	Sell	12,468,470 -281,500	-2%	-$1.32M	0.01%	1247
2013 Q4	$63.9M	Buy	12,749,970 +7,981,200	+167%	+$40M	0.01%	1188
2013 Q3	$29.7M	Hold	4,768,770	–	–	﹤0.01%	1535
2013 Q2	$21.7M	Buy	+4,768,770	New	+$21.7M	﹤0.01%	1633